Simcere Pharmaceutical Group Limited
SMHGF
$0.6697
-$0.0641-8.74%
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -0.86% | 129.44% | -0.31% | -166.37% | -2.36% |
| Total Depreciation and Amortization | -0.86% | 1.64% | 0.31% | -2.48% | -2.36% |
| Total Amortization of Deferred Charges | -0.86% | 6.18% | 0.31% | 125.64% | -2.37% |
| Total Other Non-Cash Items | -0.86% | -90.46% | 0.31% | 199.62% | 2.36% |
| Change in Net Operating Assets | -- | -- | -0.31% | -- | -- |
| Cash from Operations | -0.86% | 272.22% | 0.31% | 375.21% | 2.36% |
| Capital Expenditure | -- | -- | -0.31% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | 0.31% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | 0.31% | -94.87% | -2.36% |
| Other Investing Activities | 0.86% | -899.39% | 0.31% | -88.03% | -2.36% |
| Cash from Investing | 0.86% | -52.96% | -0.31% | -118.91% | -2.36% |
| Total Debt Issued | 0.00% | 67.19% | 0.00% | -3.91% | 0.00% |
| Total Debt Repaid | 0.00% | -231.25% | 0.00% | 63.36% | 0.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 0.00% | -67.36% | 0.00% | -389.57% | 0.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -0.31% | -- | -- |
| Other Financing Activities | 0.00% | 4,533.51% | 0.00% | 135.54% | 0.00% |
| Cash from Financing | -0.86% | 170.20% | -0.31% | 18.01% | 2.36% |
| Foreign Exchange rate Adjustments | -0.73% | -67.69% | 0.31% | -40.38% | -2.38% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -0.86% | 270.99% | -0.31% | -153.95% | -2.36% |